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ABSTRACT
Background: To interpret changes of balance and mobility in people with Alzheimer’s disease (AD), we require
measures of balance and mobility that have demonstrated reliability in this population. The aim of the study
was to determine the safety, feasibility and retest reliability of clinical and forceplate balance and mobility
measurements in people with AD.
Methods: Relative and absolute reliabilities were examined in 14 older people with mild to moderate AD.
Relative reliability was calculated using the intraclass correlation coefficient, two-way mixed model (ICC3,1).
Absolute reliability was calculated using the standard error of measurement (SEM), the minimum detectable
change (MDC) and the coefficient of variation (CV).
Results: All measurements were clinically feasible and could be safely administered. ICC values were excellent
and CVs were less than 11% in all clinical balance and mobility measures except the Timed Up & Go test
with cognitive or manual task (ICC3,1 = 0.5 and 0.7, and CV = 14% and 10%, respectively). Most balance
and mobility measures tested on the NeurocomTM forceplate (modified Clinical Test of Sensory Interaction
on Balance, Walk Across (step width, step length parameters), and Sit to Stand (rising index parameter)) had
excellent relative reliability (ICC3,1 ranging from 0.75 to 0.91). ICC values were fair to good for the other
measures.
Conclusions: Retest reliability of the balance and mobility measures used in this study ranged between fair to
good, and good to excellent. Clinicians should consider retest reliability when deciding which balance and
mobility measures are used to assess people with AD.
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Introduction
Older people with Alzheimer’s disease (AD) have
greater balance and mobility impairments, and
corresponding falls risk, compared with their
cognitively intact peers (Manckoundia et al., 2006;
Rolland et al., 2009). For clinicians to be able to
interpret changes in balance and mobility in people
with AD in response to interventions, measures
of balance and mobility with demonstrated retest
reliability in people with AD are required. It is also
important that measures of balance and mobility
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used to assess populations with increased risk such
as those with AD are safe and feasible to implement.
Reliability can be either relative or absolute
(Atkinson and Nevill, 1998). Relative reliability
provides an estimate of the ability of a measurement
procedure to differentiate among people (Atkinson
and Nevill, 1998), rather than an estimate of meas-
urement consistency (Stratford, 1989). Correlation
coefficients are commonly used to determine
relative reliability. Absolute reliability provides an
estimate of measurement consistency and this type
of reliability provides a reference threshold for the
amount of change required for a statistically signi-
ficant difference in a repeated measure (Stratford,
1989; Bruton et al., 2000). The standard error
of measurement (SEM), the minimum detectable
change (MDC) and the coefficient of variation
Reliability of balance and mobility measures in AD 1153
(CV) are common ways of evaluating absolute
reliability. To fully evaluate retest reliability, relative
and absolute estimates of retest reliability should be
used together (Bruton et al., 2000).
Most measures of balance and mobility tested
in older cognitively intact people have good relative
and absolute retest reliability. However, measures
of reliability are specific to the populations and
testing procedures used (Phillips et al., 1993),
therefore results of studies with cognitively intact
older people may not apply to people with AD.
In particular, measures with complex instructions
or tasks may have lower reliability in people with
cognitive impairment (Tappen et al., 1997).
Few previous studies have examined retest
reliability of balance and mobility measures in
people with cognitive impairment. One such study
(van Iersel et al., 2007) of 39 people with dementia
reported moderate to high retest reliability (ICCs =
0.56–0.97) of the Berg Balance Scale, Tinetti gait
and balance test score, the Timed Up & Go (TUG)
and walking tests over two weeks and sensitivity to
change (responsiveness index 0.4 to 7.2). Another
study of 12 people with dementia reported high
retest reliability (ICC = 0.87) of the TUG over
one week, although a quarter of participants were
unable to perform the test (Thomas and Hageman,
2002). While these studies suggest that relative
retest reliability might be adequate for people with
dementia, a limitation of these two previous studies
is that estimates of absolute reliability were not
reported. In addition, the types of dementia were
not specified. Knowing dementia type is important
because cognitive and physical performance differs
between dementia types (Mitnitski et al., 1999), and
so reliability may also differ.
Of particular interest is the reliability of balance
and mobility measures in people with AD because
this is the most common condition causing
dementia. In a study of 33 institutionalized people
with AD the retest reliability of the Timed Stand
and Walk test (modified TUG) and walking tests
one week apart was moderate to high (ICCs = 0.50–
0.84) (Tappen et al., 1997). However, because of
the severity of participant symptoms (later stages
of AD) test modifications were required, and so
results may not be applicable to tests using standard
procedures. In another study of 20 people with mild
to moderate AD, ICCs of walking tests measured
one week apart were high (ICC > 0.86) and
CV and MDC values were good (Wittwer et al.,
2008). However, a limitation of this study was
that it focused on gait measurement and did not
include more complex balance and mobility tasks.
Neither study reported the feasibility or safety of
the procedures for people with AD (Tappen et al.,
1997; Wittwer et al., 2008).
Forceplate technology has also been used to
demonstrate impaired balance and mobility in
people with mild to moderately severe AD (Chong
et al., 1999; Manckoundia et al., 2006; Leandri
et al., 2009). Unfortunately, the safety, feasibility
and retest reliability of forceplate measures of
balance and mobility have not been investigated
in people with AD. This is a limitation because
information about the retest reliability of clinical
and forceplate balance and mobility measures would
facilitate the interpretation of results and the safety
and feasibility would assist in judging the suitability
of these measures for research and clinical use with
people with AD.
Given these considerations, the primary purpose
of this study was to examine the absolute and
relative retest reliability of commonly used clinical
and instrumental (forceplate) measures for balance
and mobility performance in people with AD. The
secondary purpose of the study was to determine
the safety and feasibility of these tests.
Methods
Participants
The participants were a subsample from an ongoing
study investigating the effectiveness of an exercise
program in people with AD, who had agreed to
undergo a repeat assessment one week after this
scheduled baseline or post intervention assessment
for that study. Volunteers for this study were at least
65 years old, had a diagnosis of AD (confirmed by
a medical practitioner) of mild to moderate severity
(Mini-Mental State Examination score ≥ 10), were
independently mobile, and lived in the community.
Of 17 participants from the exercise study who were
approached to participate in this reliability study,
14 agreed to participate (82% response rate). Main
reasons for declining participation were related to
not wanting to do another detailed assessment.
The study was approved by the relevant Human
Ethics Committees and written informed consent
was obtained from participants or their carers.
Procedure
Participant profile information was collected which
included the Mini-Mental State Examination
(MMSE; Folstein et al., 1975), the Frontal
Assessment Battery (FAB; Dubois et al., 2000),
medical conditions and medications, and history of
falls in the preceding 12 months (verified by carer).
Participants then completed an assessment
battery of balance and mobility tests on two
occasions held approximately one week apart. Due
to the complexity of the balance system (Huxham
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et al., 2001), a multidimensional framework was
used to select measures to provide a broad range
of domains related to global balance performance,
including static and dynamic balance, maintaining
stability during functional tasks, and single and
dual task performance. A single assessor with six
years of physiotherapy experience conducted all
measurements. To assess feasibility, the percentage
of participants who could perform the tests each
session was recorded. To assess safety, issues such
as a slip or fall during testing were systematically
recorded.
Participants were given simple, clear instruc-
tions. To help participants remember the full task,
verbal cues were given during each test, and
demonstrations were performed either before or
during the tests (if applicable). Each participant
was allowed to practice each task prior to data
collection on each test occasion. Participants were
tested in bare feet to remove any performance
variability associated with different shoes (Menant
et al., 2008). The detailed test procedure including
instructions and verbal cues for each measurement
is available from the authors. All measurements
were conducted at the Gait and Balance Laboratory
of the National Ageing Research Institute.
The Functional Reach (FR) test assessed dynamic
bilateral stance balance (Duncan et al., 1990). The
participant stood alongside (but not leaning against)
a wall with feet 10 cm apart, their dominant arm
raised to 90 degrees. The participant was instructed
to reach forward as far as possible (FR score was the
additional reach from the starting position in cm).
The Step Test (ST) assessed dynamic single leg
standing balance (Hill et al., 1996). The participant
stood with feet parallel and 10 cm apart, with a
7.5 cm block placed 5 cm directly in front. The
participant was instructed to place the whole foot
onto the block, then return it fully back down to the
floor repeatedly as fast as possible for 15 seconds.
Each leg was tested separately, and performance on
the left or right side with the least number of steps
was used for data analysis.
The Timed Up & Go (TUG) test (Podsiadlo and
Richardson, 1991) required the participant to stand
up from a standard chair, walk 3 meters at their
usual pace, turn, walk back and sit down again in the
chair (timed in seconds). This task was reassessed
under two dual task conditions: (1) TUG with
manual task, where the participant completed the
TUG (as described above) while carrying a full cup
of water; and (2) TUG with cognitive task, where
the participant completed the TUG while counting
backwards by 3s from a randomly selected number
between 20 and 100 (Shumway-Cook et al., 2000).
The modified Clinical Test of Sensory Interaction
on Balance (mCTSIB) assessed static balance
Figure 1. Feet position during the modified Clinical Test of Sensory
Interaction on Balance (mCTSIB) and the Limits of Stability test
(LOS) on the NeuroCom Balance MasterTM.
under four sensory conditions (eyes open and
eyes closed standing on a firm surface, and eyes
open and eyes closed while standing on foam).
A safety harness was worn to prevent a fall, but
did not constrain trunk movement during normal
balance adjustments. Each condition consisted
of three trials of 10 seconds, assessed on the
NeuroCom Balance MasterTM (long plate). The
participant’s feet were positioned apart at one of
three standardized foot positions related to the
participant’s height according to the manufacturer’s
instructions (NeuroComTM International Inc.,
2003) (Figure 1). The assessor stood beside the
platform, and if a carer was present, the carer was
asked to stand on the other side of the platform,
to reassure the participant that they would be safe.
Instructions were to look straight ahead and stand
as still as possible. Sway velocity (degrees/second)
in each condition was measured, and a summary
composite score was used for data analysis.
The Limits of Stability (LOS) was assessed using
the NeuroCom Balance MasterTM (long plate)
and measured participants’ ability to move their
center of gravity (COG) by shifting their weight
to eight targets positioned in an ellipse, with the
perimeter at 100% of their theoretic limits of
stability (computed by the NeuroComTM system,
based on the participant’s height) (Figure 2). The
test was performed with the same feet position as
the mCTSIB, and the safety harness was worn.
Instructions were to move the cursor on the screen
from the centre box directly to each target box (one
of the eight targets highlighted on the screen) as
fast and as close to the target as possible and then
hold steady for 8 seconds. A practice was allowed
prior to the actual test for each direction. Measures
included Reaction Time (seconds), Movement
Velocity (degree/second), Maximum Excursion (%
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Figure 2. One centered box and eight target boxes positioned at
the 100% of the Limits of Stability in the Limits of Stability test
(LOS) on the NeuroCom Balance MasterTM. The cursor (indicating
the person’s center of pressure) is the stick figure.
of LOS boundary) and Directional Control (%) in
each of the eight directions. A summary composite
score integrating data from each of the eight
directions assessed, computed by the NeuroComTM
system for each measure (described above), was
used for analysis.
The Walk Across test assessed gait characteristics,
including step width (cm), step length (cm),
and walking speed (cm/second) as the participant
walked at a comfortable speed across the long plate
(NeuroCom Balance MasterTM). To start the test,
the participant was positioned approximately 90 cm
in front of the platform, on a surface level with
the platform. Three trials were conducted and the
average score was used for analysis.
The Step Quick Turn test measured stability
during turning on the NeuroCom Balance
MasterTM forceplate. The test required the
participant to take two steps forward, quickly turn
and return to the starting point. To start the
test, participants were positioned at the front of
the forceplate. Performance was assessed turning
separately to the left and to the right, with three
trials in each direction. The participant was advised
to use their preferred method of turning. Average
measures of turn time (seconds) and turn sway
(degrees/second) were derived for turning to the
right and turning to the left. Data for the turn
direction with worst (highest) score for turn time
and turn sway were used in analyses.
The Timed Chair Stand test assessed functional
leg muscle strength (Whitney et al., 2005). Each
participant was asked to sit at the front edge of
a 45 cm-high chair with their arms crossed, and
instructed to stand up fully and sit down five times
as quickly as possible. The number of sit-to-stand
repetitions was counted aloud to ensure participants
were aware of the number of repetitions completed
and to encourage them to complete the task. Time
to complete the task was recorded (seconds).
Sit to Stand (on the NeuroCom Balance
MasterTM) was used to assess stability during
standing up from a seated position without upper
extremity assistance. The participant sat on a
40 cm-high block, positioned centrally on the
forceplate. The test was performed three times
on the forceplate. Measures of the force exerted
by the legs during the rising phase (rising index),
expressed as% body weight, and COG sway velocity
(degrees/second) were reported.
Statistical analyses
The required sample size was calculated using the
method described by Walter et al. (1998). The
few studies investigating retest reliability of physical
performance measures in people with dementia
or AD have reported reliability coefficients in the
range of 0.6 and 0.9 (Thomas and Hageman, 2002;
Lorbach et al., 2007). The formula of Walter et al.
(1998) for sample size estimate for intra-rater reli-
ability studies requires an estimate of the desired /
preferred reliability (informed by other studies if
data are available), and an estimate of the lowest
acceptable level of reliability. Using this formula
and adopting an optimal/desired reliability level of
ICC = 0.9, and a lowest acceptable reliability of
ICC = 0.65, the sample size estimate indicated 14
participants were required.
Relative reliability was evaluated using ICCs,
two-way mixed model (ICC3,1). ICCs were
interpreted as excellent (values > 0.75); fair to good
(ICCs 0.40–0.75); and poor (ICCs < 0.40) (Shrout
and Fleiss, 1979).
Three indices of absolute reliability were used.
First, the standard error of measurement (SEM)
which expresses measurement error in the same
units as the measurement itself was calculated using
the mean square error (MSE) from a repeated
measure ANOVA, where SEM =
√
MSE (Stratford
and Goldsmith, 1997; Atkinson and Nevill, 1998).
Second, the minimum detectable change (MDC95),
an estimate of the smallest change in score that
can be detected beyond measurement error, was
calculated for each test (MDC95 = SEM ×
√
2 ×
the z score of 1.96) (Standford, 2004). Third, the
coefficient of variation (CV), a measure of variability
that is expressed as a dimensionless coefficient, was
calculated. This allows the reliability of different
measurement procedures to be compared (Atkinson
and Nevill, 1998). The CV was calculated based
on the mean square error term of logarithmically
transformed data as described by Hopkins (2000).
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Table 1. Participants’ characteristics
CHARACTERISTICS VA LUES
.......................................................................................................................................................
Age (years) 79.57 ± 6.19
Sex (male : female) 7:7
Height (cm) 163.75 ± 12.51
Living arrangements
- Home, no carer – n (%) 3 (21.4)
- Home, with carer – n (%) 11 (78.6)
Most common co-morbidities
- Arthritis / osteoporosis – n (%) 6 (42.9)
- Lower limb joint replacement – n (%) 3 (21.4)
- Back pain – n (%) 4 (28.6)
- Hypertension – n (%) 8 (57.1)
- Diabetes Mellitus – n (%) 5 (35.7)
Number of prescription medications 6.29 ± 3.10
Weight (kg) 66.12 ± 13.80
MMSE 21.43 ± 5.00
FAB 13.14 ± 2.35
Number of falls in the past 12 months 0.93 ± 1.98
Number of fallers in the preceding year –
n (%)
4 (28.6)
Number of multiple fallers in the
preceding year – n (%)
2 (14.3)
Test-retest interval (days) 8.21 ± 3.21
Values are mean ± standard deviation (SD), or as otherwise
indicated.
MMSE = Mini-Mental State Examination; FAB = Frontal
Assessment Battery.
Statistical analyses were performed with SPSS
Graduate Student Version 16.0 for Windows, and
Microsoft Excel.
Results
Fourteen participants (50% female; mean age
79.7 years) were recruited; primarily through
memory clinics. Sample demographics are summar-
ized in Table 1.
All measurements included in this study could
be administered safely to participants with AD.
However, on one or both test occasions, 30%
of participants were incapable of performing the
Timed Up & Go test with the cognitive task. No
participants had any falls or slips during testing.
Table 2 presents the percentage of participants who
could complete each test, the ICC values, and
the three absolute reliability values. As the table
shows, ICC retest estimates were excellent (above
0.75) for most clinical measures (Functional Reach,
Step Test, Timed Chair Stand and Timed Up &
Go (TUG) test-single task). ICCs for the TUG
test assessed under dual task conditions (manual
and cognitive) indicated fair to good reliability
(0.40–0.75). The CVs were less than 10% for
Functional Reach and TUG test; but slightly larger
for Step Test, Timed Chair Stand, the TUG with a
secondary manual task and TUG with a cognitive
task, where the CVs ranged from 10.5% to 14.1%.
ICC values for three of the balance and mobility
measures tested on the NeuroComTM forceplate
[the modified Clinical Test of Sensory Interaction
on Balance, Walk Across (for step width and step
length parameters), and Sit to Stand (rising index
parameter)] ranged from 0.75 to 0.91, indicating
excellent reliability. The CVs for these measures
were approximately 14%, with the exception of the
Sit to Stand test (rising index parameter, CV =
7.7%). For the Limits of Stability (LOS) test, ICC
values for all parameters ranged from 0.48 to 0.71
and the CVs ranged from 6.2% to 14.7%. ICCs for
the Step Quick Turn measures (turn sway and turn
time) were fair to good, and CVs were 10.5% and
14.4%.
MDC95 values are also reported in Table 2.
These provide the range of scores considered to be
within the range of measurement error, in the units
of the actual measurement. For example, using the
Step Test in an intervention study with participants
with AD, a change of more than 2.42 steps would be
required to be confident that the difference reflected
true change.
Discussion
Generally, the clinical measures of balance and
mobility included in the study showed excellent
retest reliability. Given the multidimensional
nature of balance performance, these results,
in combination with previous studies that have
demonstrated high retest reliability for the Berg
Balance Scale and the TUG in people with
dementia (Thomas and Hageman, 2002; van Iersel
et al., 2007), give clinicians confidence that these
measures can be used to evaluate changes in
response to interventions or disease progression
over time in this clinical group. More complex
clinical measures, such as the dual task TUG, had
lower levels of reliability. This could in part be due
to the impaired ability of participants to process
the more complex instructions associated with these
tasks.
Overall, assessments using the NeuroComTM
forceplate showed good reliability, with excellent
ICCs for the modified Clinical Test of Sensory
Integration on Balance, the Walk Across (step
width and step length), and Sit to Stand (rising
index variable) measures. Although conducted
on the forceplate, these measures incorporate
ordinary tasks (e.g. standing and walking) into
the assessment. This familiarity could partially
explain their higher level of reliability compared
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with some of the more complex forceplate measures.
The remaining forceplate measures demonstrated
poor (Sit to Stand sway) or only fair to good
ICCs (LOS velocity, reaction time and maximum
excursion; Walk Across speed; and the Step Quick
Turn sway and turn time measures). The CVs
were substantially larger as well for most of these
measures. Several of these tasks do seem to require
the ability to plan a movement sequence, which
is likely to be a factor in the lower reliability for
these tasks. As such, use of these measures may
need to be considered carefully in people with AD,
as substantially larger effect or group differences
will need to be evident for significant changes to
be observed using these measures compared to
measures with higher ICCs and lower SEMs, CVs
and MDCs.
Almost all of the measures with good to
excellent ICCs also revealed acceptable levels of
the CVs (≤ 11%). In two forceplate measures –
the modified CTSIB and Walk Across (step width) –
the ICCs were excellent but had relatively high
CVs (approximately 14%) indicating moderate
differences in the repeated measures compared with
their mean scores. The implications of this are that
these measurements could only reliably differentiate
moderate to large changes in performance. The
relatively high MDC of the modified CTSIB
suggests that large changes are required to ensure
actual clinical change in people with AD.
The absolute reliability estimates for balance
and mobility measures have rarely been reported
in people with AD. However, one previous study
investigated the absolute reliability (CV, MDC)
of gait analysis using an instrumented walkway
(GAITRite R© system) in 20 people with mild to
moderate AD (Wittwer et al., 2008). The CVs
and MDCs of the gait measures in our study
are generally higher suggesting poorer reliability
compared with the CV and MDC values of the
previous study. This is despite the fact that they were
derived from a similar sample. It is possible that the
shorter walkway in this study (360 cm compared
with the 830 cm walkway in the previous study)
meant that the acceleration and deceleration phases
of walking were included in the gait analysis. This
may have impacted on the reliability. Therefore, for
assessment of gait measures in research and clinical
practice, we recommend using a longer walkway to
measure only steady state walking.
Even though we found good reliability for
most clinical measures, and an acceptable level of
reliability for the force platform balance measures,
these derived from a relatively small sample and
this could possibly limit the generalizability of the
results. Further research with larger samples would
be able to determine the reliability estimates with
greater precision. A number of factors influence
a clinician’s choice of which measures of balance
and mobility to use for specific clinical populations.
Retest reliability is an important consideration.
Using the procedures reported in this study, those
measures with lower levels of retest reliability should
be considered with some caution for people with
AD. However, retest reliability for these measures
may be able to be improved with additional levels of
practice, or different instructions being used.
Our results indicate that the clinical and force-
plate measures of balance and mobility included in
the current study were safely undertaken by people
with mild to moderate AD. The Timed Up & Go
test with cognitive task proved the least feasible
measure, with four out of 14 participants not being
able to complete the test on either test occasion.
This might suggest that selecting an easier cognitive
task such as reciting backwards the months of the
year may be more applicable for this population.
Conclusions
Given additional cues and appropriate demonstra-
tion, all except one of the clinical and instrumental
balance and mobility measures reported in this
study are feasible and can be safely used to assess
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